Caliber Wealth Management (Utah)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,747
Closed -$459K 61
2022
Q4
$459K Buy
+1,747
New +$468K 0.35% 59

Other funds holding AMGN

Caliber Wealth Management (Utah)'s AMGN Position: Q1 2023 in Review

Caliber Wealth Management (Utah) sold out of Amgen (AMGN) in Q1 2023, closing a stake of 1,747 shares — an estimated $459K sold.

Caliber Wealth Management (Utah) first reported a position in AMGN in Q4 2022 and held it in 1 quarter. The position peaked at $459K in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Caliber Wealth Management (Utah) reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Caliber Wealth Management (Utah) sold 1,747 Amgen shares in Q1 2023, an estimated $459K.
  • Caliber Wealth Management (Utah) first reported a position in Amgen in Q4 2022 and held it in 1 quarter.
  • Caliber Wealth Management (Utah)'s Amgen position peaked at $459K in Q4 2022.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Caliber Wealth Management (Utah)'s 13F filing for Q1 2023, filed 10 Apr 2023.